V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10335969 | 10056452 | 1.78 | 81.3 | null | 2019-06-02 | 2019-06-02 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101325059 |
| 10336057 | 10056453 | 1.67 | null | Palliative (P) | 2019-12-28 | 2020-01-19 | Carboplatin + Liposomal Doxorubicin | 02 | N | CETUXIMAB | 100151259 |
| 10336083 | 10056454 | 1.64 | 135.4 | null | 2019-04-08 | 2019-04-15 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100595021 |
| 10336145 | 10056456 | 1.48 | 86 | null | 2020-10-18 | 2020-10-18 | BUSULFAN | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101618248 |
| 10336195 | 10056457 | 1.71 | 87.7 | Curative (C) | 2019-05-21 | 2019-06-14 | PERTUZUMAB + TRASTUZUMAB | 02 | N | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 100606987 |
| 10336205 | 10056458 | 1.55 | 86.6 | null | 2018-08-24 | 2018-08-24 | null | 02 | null | NIRAPARIB | 101294257 |
| 10336641 | 10056460 | 1.75 | null | Palliative (P) | 2021-04-16 | 2021-04-29 | FLUOROURACIL | 02 | N | BORTEZOMIB + THALIDOMIDE | 101287785 |
| 10336803 | 10056462 | 1.48 | 76.8 | null | 2018-03-29 | 2018-04-01 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | null | CABOZANTINIB | 100623473 |
| 10336953 | 10056465 | 1.5 | null | null | 2020-03-06 | 2020-03-08 | Niraparib | N | null | BUSULFAN | 101396816 |
| 10337070 | 10056466 | 1.66 | 78 | null | 2022-04-03 | 2022-04-03 | Cetuximab 14 day | 02 | null | BORTEZOMIB + THALIDOMIDE | 100270152 |
| 10337202 | 10056467 | 1.8 | 0 | null | null | 2018-01-24 | Niraparib | null | null | NIRAPARIB | 100709955 |
| 10337412 | 10056469 | 1.67 | 79.3 | Palliative (P) | 2021-09-29 | 2022-01-14 | Cisplatin + Radiotherapy | 02 | N | CETUXIMAB | 100111076 |
| 10337455 | 10056470 | 1.69 | 78.9 | null | null | 2017-03-25 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100107589 |
| 10337457 | 10056471 | 1.8 | 49.3 | null | 2020-02-02 | 2020-02-02 | Azacitidine | 02 | null | AZACITIDINE | 101242304 |
| 10337554 | 10056472 | 1.74 | 95.9 | Palliative (P) | null | 2019-03-19 | Palbociclib | 02 | N | PALBOCICLIB | 100725354 |
| 10337591 | 10056473 | 1.76 | 0 | null | 2018-12-05 | 2018-12-07 | null | 02 | null | CISPLATIN | 101583173 |
| 10337920 | 10056474 | 1.78 | 88.2 | null | null | 2021-07-28 | Cisplatin + Radiotherapy | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100183596 |
| 10337954 | 10056476 | 1.75 | 98.6 | null | null | 2020-07-10 | Cabazitaxel | 02 | null | CABAZITAXEL | 100774395 |
| 10338059 | 10056477 | 1.77 | 80 | Palliative (P) | 2018-04-02 | 2018-06-24 | Cisplatin 7 day | N | null | NIRAPARIB | 100219080 |
| 10338108 | 10056478 | 1.68 | 97.4 | null | 2018-03-17 | 2018-03-26 | DABRAFENIB | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100291487 |
| 10338187 | 10056479 | 1.75 | 78 | Palliative (P) | 2017-06-11 | 2017-07-23 | AFATINIB | 02 | N | AFATINIB | 101086184 |
| 10338384 | 10056480 | 1.75 | 92.6 | Palliative (P) | null | 2019-02-15 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100163825 |
| 10338492 | 10056482 | 1.87 | 59.1 | null | 2020-09-23 | 2020-10-14 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN | 100307331 |
| 10338677 | 10056485 | 1.74 | 87.7 | Curative (C) | 2020-02-12 | 2020-06-04 | Palbociclib | 02 | null | PALBOCICLIB | 101013846 |
| 10339131 | 10056486 | 1.8 | 92.4 | null | 2017-06-26 | 2017-07-07 | Azacitidine | 02 | null | AZACITIDINE | 101516804 |
| 10341174 | 10056491 | 1.72 | 48 | null | null | 2017-01-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100927642 |
| 10342041 | 10056495 | 0 | 103 | null | 2020-03-17 | 2020-07-08 | Chlorambucil | N | null | CHLORAMBUCIL | 100515927 |
| 10342685 | 10056497 | 1.82 | 91.4 | null | 2019-10-19 | 2020-02-03 | Azacitidine | 02 | null | AZACITIDINE | 100342117 |
| 10342761 | 10056498 | 1.53 | 78.3 | Curative (C) | 2017-09-26 | 2017-09-27 | Palbociclib | 02 | Y | PALBOCICLIB | 101227589 |
| 10343318 | 10056499 | 0 | null | null | null | 2016-07-27 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101271776 |
| 10343810 | 10056500 | 1.55 | 61.1 | null | 2021-03-07 | 2021-03-22 | IPILIMUMAB + NIVOLUMAB | 02 | null | CHLORAMBUCIL | 100932909 |
| 10343942 | 10056501 | 1.75 | 40.3 | null | 2018-12-06 | 2018-12-08 | CABOZANTINIB | 02 | null | NIRAPARIB | 100348848 |
| 10344277 | 10056502 | 1.68 | 73.5 | Palliative (P) | null | 2021-09-20 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100030070 |
| 10344617 | 10056503 | 1.61 | 63 | 03 | 2021-05-14 | 2021-06-12 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101711570 |
| 10344706 | 10056504 | 1.48 | 52.1 | Not known (9) | 2021-09-03 | 2022-01-27 | CVD | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100229239 |
| 10344794 | 10056505 | 1.5 | 57.5 | null | 2019-11-07 | 2020-07-26 | Palbociclib | N | null | PALBOCICLIB | 101238011 |
| 10344832 | 10056506 | 1.62 | 84 | null | 2018-05-15 | 2018-05-24 | Trifluridine + Tipiracil | 02 | null | TIPIRACIL + TRIFLURIDINE | 101849123 |
| 10344995 | 10056507 | 1.74 | 0 | null | null | 2018-11-12 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 100687509 |
| 10344996 | 10056508 | 1.75 | 0 | Palliative (P) | 2017-10-07 | 2018-04-10 | BORTEZOMIB + THALIDOMIDE | 02 | N | NIRAPARIB | 101051326 |
| 10345100 | 10056509 | 1.75 | 71.6 | 03 | null | 2020-10-03 | PERTUZUMAB + TRASTUZUMAB | 02 | Y | IPILIMUMAB + NIVOLUMAB | 100052207 |
| 10345183 | 10056510 | null | 88.3 | 03 | 2020-08-08 | 2020-08-11 | Melphalan IV High dose | 02 | N | MELPHALAN | 101118914 |
| 10345985 | 10056511 | 1.76 | 44.8 | Adjuvant (A) | 2019-10-03 | 2019-10-11 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101854550 |
| 10346155 | 10056512 | 1.84 | 68.8 | null | 2018-08-18 | 2019-04-29 | Chlorambucil | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101144118 |
| 10347095 | 10056513 | 1.56 | 72.4 | Neo-adjuvant (N) | 2018-09-17 | 2018-09-19 | GDP | 02 | null | FLUOROURACIL | 101486996 |
| 10347359 | 10056514 | 1.78 | 69.1 | null | null | 2018-04-19 | Chlorambucil | 02 | null | CHLORAMBUCIL | 100215681 |
| 10347573 | 10056515 | 1.59 | 80 | Disease modification (D) | 2019-05-19 | 2019-05-19 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 101175252 |
| 10347790 | 10056516 | 1.64 | 87.4 | Palliative (P) | 2020-05-08 | 2020-05-08 | Cyclophosphamide oral | 02 | null | CYCLOPHOSPHAMIDE | 100122337 |
| 10348764 | 10056517 | 1.72 | 88.3 | null | null | 2022-01-13 | null | null | null | DABRAFENIB | 100430393 |
| 10349148 | 10056518 | 1.7 | 68.8 | null | null | 2020-10-27 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101200894 |
| 10349266 | 10056519 | 1.45 | 68.8 | null | null | 2018-11-01 | Doce + Pertuzumab + Trastuz IV Load | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101278660 |